Quick Answer
FEMASYS INC reported R&D Expense of $7.58 million for fiscal year 2025.
FEMASYS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $7.58M | -7.8% |
| 2024 | $8.22M | +14.0% |
| 2023 | $7.21M | +24.0% |
| 2022 | $5.81M | +42.3% |
| 2021 | $4.08M | -1.1% |
| 2020 | $4.13M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.38M | -40.0% | -2.3% |
| June 30, 2025 | $1.41M | -28.4% | -52.4% |
| March 31, 2025 | $2.97M | +67.6% | +28.9% |
| September 30, 2024 | $2.30M | +11.1% | +16.6% |
| June 30, 2024 | $1.98M | +29.4% | +11.6% |
| March 31, 2024 | $1.77M | +15.2% | -14.6% |
| September 30, 2023 | $2.07M | +25.8% | +35.7% |
| June 30, 2023 | $1.53M | +3.7% | -0.7% |
- FEMASYS INC showed a decrease of -7.8% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, FEMASYS INC’s r&d expense has grown by 83.5% (from $4.13 million to $7.58 million).
- The most recent figure is from FEMASYS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: